Intelligent Bio Solutions
INBS
7 hedge funds and large institutions have $53K invested in Intelligent Bio Solutions in 2025 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 8 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
0.9% less ownership
Funds ownership: 1.49% → 0.6% (-0.9%)
42% less funds holding
Funds holding: 12 → 7 (-5)
63% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 8
96% less capital invested
Capital invested by funds: $1.38M → $53K (-$1.33M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$33K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$10.3K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$24 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
-$687K |
| 2 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
-$435K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$99.6K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$60K |
| 5 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
-$45.6K |
INBS Hedge Fund Activity: Q4 2025 in Review
7 of the 8,267 institutional investors tracked by Wall St. Rank reported a position in Intelligent Bio Solutions (INBS) for Q4 2025, worth a combined $53K — down 96% from $1.38M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of INBS and 3 opened new positions — a net loss of 5 holders — while 1 trimmed existing stakes and 1 added.
The largest buyer was UBS Group, opening a new position worth an estimated $33K. The largest seller was Alyeska Investment Group, exiting entirely with an estimated $687K sold.
- 7 institutional investors held Intelligent Bio Solutions (INBS) as of Q4 2025, down from 12 in Q3 2025.
- Funds reported $53K of Intelligent Bio Solutions stock for Q4 2025, down 96% quarter-over-quarter.
- 3 funds opened new Intelligent Bio Solutions positions in Q4 2025 and 8 closed out, a net change of -5 holders.
- The largest Intelligent Bio Solutions buyer in Q4 2025 was UBS Group, an estimated $33K added.
- The largest Intelligent Bio Solutions seller in Q4 2025 was Alyeska Investment Group, an estimated $687K sold.
Based on aggregated 13F filings for Q4 2025.